(Q80492373)
Statements
Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage (English)
Kerstin Benz
Stephan R Orth
Aurelia Simonaviciene
Wolfgang Linz
Ursula Schindler
Hartmut Rütten